Physician profile
Munis Raza
NPI 1164807087
$16,167.55
in general payments reported to CMS, 2019-2025
34 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,201 · 2020: $843 · 2021: $2,342 · 2022: $2,597 · 2023: $6,059 · 2024: $579 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,153 · Travel and Lodging: $4,030 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,152.75 |
| Travel and Lodging | $4,030.11 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,025.09 | 2019-2025 | Perclose Prostyle, Coroflow, Jeti Peripheral Catheter |
| Medtronic, INC. | $2,719.04 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Edwards Lifesciences Corporation | $1,263.43 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $995.04 | 2020-2024 | Emerge Push, Rotablator Rotational Atherectomy System Console Kit, Watchman Access System |
| Janssen Pharmaceuticals, INC | $672.94 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $608.91 | 2019-2023 | Lifevest |
| Terumo Medical Corporation | $544.97 | 2020-2023 | Glidewire |
| Abiomed | $448.39 | 2019-2021 | |
| Cardiovascular Systems INC. | $407.75 | 2020-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals Lp | $305.18 | 2020-2024 | Farxiga |
| Amgen INC. | $267.74 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $211.50 | 2022-2025 | |
| Inari Medical, INC. | $195.68 | 2022 | |
| Teleflex LLC | $172.64 | 2022-2023 | Turnpike, Trapliner, Raider |
| Actelion Pharmaceuticals US, INC. | $156.96 | 2025 | Opsumit, Uptravi |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $143.62 | 2025 | Paradise Ultrasound Renal Denervation System |
| Merck Sharp & Dohme LLC | $137.01 | 2023-2025 | Verquvo, Winrevair |
| Astellas Pharma US INC | $120.28 | 2021 | |
| Osprey Medical INC | $106.79 | 2021 | |
| Lantheus Medical Imaging, INC. | $105.57 | 2021 | |
| Medtronic Vascular, INC. | $71.36 | 2020 | |
| Cardinal Health 200 LLC | $64.93 | 2019 | |
| Cvrx, INC. | $64.51 | 2022-2023 | Barostim Neo System |
| Angiodynamics, INC. | $58.53 | 2021 | |
| Akcea Therapeutics, INC. | $49.56 | 2019 | |
| United Therapeutics Corporation | $35.96 | 2024 | Tyvaso |
| Novo Nordisk INC | $35.48 | 2025 | Ozempic, Rybelsus |
| Chiesi USA, INC. | $33.93 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $31.77 | 2023-2025 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $30.50 | 2023-2024 | Dupixent, Evkeeza |
| Asahi Intecc USA, INC. | $27.23 | 2022 | |
| Silk Road Medical, INC. | $23.87 | 2022 | |
| W. L. Gore & Associates, INC. | $19.48 | 2022 | |
| Pfizer INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munis Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.